ATProto Browser

{
  "text": "Long COVID and viral reactivation are linked. Our latest trial focuses on repurposing existing, broad spectrum antivirals to reduce symptoms in adults with #LongCOVID. Our clinical trial is currently recruiting! Email CoreResearch@mountsinai.org to inquire",
  "$type": "app.bsky.feed.post",
  "embed": {
    "$type": "app.bsky.embed.images",
    "images": [
      {
        "alt": "Volunteers Needed\nLong COVID\nClinical Trial\nIcahn\nSchool of Medicine at\nMount\nSinai\nDo you have a confirmed diagnosis of Long Covid?\nYou may be eligible for a 6 month drug clinical trial involving antiviral drugs\nYou may qualify if:\n• You are over 18\n• You have a diagnosis of Long Covid from a physician\n• You are HIV negative\n• You are able to commute to our office\n• Other criteria are considered as well\n| Participation Involves:\n• Being randomly assigned into one of three groups\n• Truvada (drug)\n• Selzentry (drug)\n• Placebo\n• Attend 6 in-person study visits\n• Blood and saliva samples\n• Completion of surveys online\nStudy goal:\nWe are investigating if antiviral medications have an effect on\nLong Covid symptoms\nIRB Approved\nEffective Date: 12/17/2024\nEnd Date:7/22/2025\nPlease email\nCoreResearch@MountSinai.org\nfor more information\nLocation: 5 East 98th St, SB-18\nLead Researcher: David Putrino, PT, PhD\nSTUDY- 24-00088\nParticipation will be compensated up to $300",
        "image": {
          "$type": "blob",
          "ref": {
            "$link": "bafkreihja57meqq7hr42rbrl75lfre2ia7ufvhlppgy5d5tin6hbcmpw4e"
          },
          "mimeType": "image/png",
          "size": 459733
        },
        "aspectRatio": {
          "width": 900,
          "height": 900
        }
      }
    ]
  },
  "facets": [
    {
      "index": {
        "byteEnd": 166,
        "byteStart": 156
      },
      "features": [
        {
          "tag": "LongCOVID",
          "$type": "app.bsky.richtext.facet#tag"
        }
      ]
    }
  ],
  "createdAt": "2025-04-07T12:47:48.450Z"
}